Literature DB >> 32420110

Challenges in addressing the knowledge gap on endomyocardial fibrosis through community-based studies.

Jenisse Mbanze1, Basilio Cumbane1, Rolando Jive1, Ana Mocumbi2,3.   

Abstract

Endomyocardial fibrosis (EMF) is a poverty-related disease of unknown origin that afflicts predominantly young people of certain rural areas in low-income countries and can be used to expose global disparities in cardiovascular research. Despite affecting predominantly young people and causing high morbidity and mortality, efforts to understand its mechanisms and natural history have been hampered by the incapacity to detect the early stages of the disease in endemic areas. Dietary, environmental and infectious factors seem to combine in susceptible individuals to give rise to an inflammatory process that leads to endomyocardial damage and scar formation. Lack of awareness by health professionals and low access to health care determine late diagnosis, when complications such as chronic heart failure, thromboembolism and arrhythmia are already present. Open-heart surgery to detach the endocardial fibrous tissue and repair the atrioventricular valve, remains the last resource to prolong patients' survival. Community-based research is therefore needed to understand the epidemiology of EMF, detect early disease, uncover its pathogenesis and explore new therapeutic targets. Our research has shown that echocardiographic screening using standard criteria adds sensitivity and precision to the diagnosis, particularly in asymptomatic disease, providing an opportunity for longitudinal community-based research. However, researchers face major constraints in rural settings where EMF is endemic, including socioeconomic, cultural, geographical and administrative barriers. In presenting our experience we aim to describe the challenges and discuss the lessons learned while implementing community-based research in a highly endemic area in southern Mozambique, one of the poorest countries in the world. Additionally, we discuss how recent advances in medicine-such as use of point-of-care diagnostics, heart failure biomarkers and new imaging techniques-may open new possibilities for high quality research through collaborative partnerships and regional initiatives. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Community-based research; endomyocardial fibrosis studies

Year:  2020        PMID: 32420110      PMCID: PMC7225430          DOI: 10.21037/cdt.2019.08.07

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  48 in total

1.  Endomyocardial fibrosis mimicking a dilated cardiomyopathy in a child.

Authors:  C Chimenti; M Pieroni; A Frustaci
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

2.  Recent trends in the epidemiology of endomyocardial fibrosis in Africa.

Authors:  Ana Olga H Mocumbi
Journal:  Paediatr Int Child Health       Date:  2012-05       Impact factor: 1.990

3.  [Usefulness of magnetic resonance imaging in the assessment of endomyocardial disease].

Authors:  Jordi Estornell; María Pilar López; Fernando Dicenta; Begoña Igual; Vicente Martínez; Alberto Sonlleva
Journal:  Rev Esp Cardiol       Date:  2003-03       Impact factor: 4.753

4.  Practicalities of health survey fieldwork research in a resource limited setting: challenges and lessons learnt from Uganda.

Authors:  Julie Abimanyi-Ochom
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

5.  [Endomyocardial fibrosis in Cameroon: Echocardiographic and clinical description of a pediatric series in Yaoundé].

Authors:  D Chelo; F Nguefack; A-P Menanga; H-D Mbassi Awa; S Nguefack; S Ngo Um; J-C Gody; P-O Koki Ndombo
Journal:  Arch Pediatr       Date:  2015-12-24       Impact factor: 1.180

6.  A novel, selective, and orally available antagonist for CC chemokine receptor 3.

Authors:  Tatsuaki Morokata; Keiko Suzuki; Yohei Masunaga; Katsunari Taguchi; Koichiro Morihira; Ippei Sato; Masahiro Fujii; Satoko Takizawa; Yuichi Torii; Naoyoshi Yamamoto; Masayuki Kaneko; Toshimitsu Yamada; Koichiro Takahashi; Yasuaki Shimizu
Journal:  J Pharmacol Exp Ther       Date:  2005-12-09       Impact factor: 4.030

7.  Sub-Saharan Africa's mothers, newborns, and children: where and why do they die?

Authors:  Mary V Kinney; Kate J Kerber; Robert E Black; Barney Cohen; Francis Nkrumah; Hoosen Coovadia; Paul Michael Nampala; Joy E Lawn; Henrik Axelson; Anne-Marie Bergh; Mickey Chopra; Roseanne Diab; Ingrid Friberg; Oladoyin Odubanjo; Neff Walker; Eva Weissman
Journal:  PLoS Med       Date:  2010-06-21       Impact factor: 11.069

Review 8.  Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases.

Authors:  Fabiola Atzeni; Marco Corda; Luigi Gianturco; Maurizio Porcu; Piercarlo Sarzi-Puttini; Maurizio Turiel
Journal:  Front Med (Lausanne)       Date:  2018-02-14

9.  Prevalence and characteristics of primary left-sided valve disease in a cohort of 15,000 patients undergoing echocardiography studies in a tertiary hospital in Uganda.

Authors:  Joselyn Rwebembera; William Manyilirah; Zhang Wan Zhu; Juliet Nabbaale; Judith Namuyonga; Isaac Ssinabulya; Sulaiman Lubega; Peter Lwabi; John Omagino; Emmy Okello
Journal:  BMC Cardiovasc Disord       Date:  2018-05-04       Impact factor: 2.298

10.  Feasibility of south-south collaboration in Africa: the Uganda-Mozambique perspective.

Authors:  Judith Namuyonga; Peter Solomon Lwabi; John Omagino; Magdi Yacoub; Ana Olga Mocumbi
Journal:  Cardiovasc J Afr       Date:  2018 Jul/Aug       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.